The Oklahoma Center for the Advancement of Science and Technology(OCAST) has funded 2,519 projects at more than $254 million, attracting almost $5.3 billion in private sector and federal dollars for a return on investment of 21:1.
The University of Oklahoma Health Sciences Center is dedicated to both basic and translational research, with resources such as a Phase 1 Clinical Trials Program in the Cancer Center, a comprehensive Diabetes Center, and the only Oklahoma NIH grant to enhance collaboration between clinical and basic research missions.
The 27-acre, $100 million University Research Park, part of the Oklahoma Health Center complex, is home to 37 science-based companies.
The Samuel Roberts Noble Foundation, in Ardmore, is the largest private foundation in the country conducting plant science and agriculture research. Their rich legacy of forage development that started more than 60 years ago continues with the release of four new varieties, including a new wheat, rye, oat and triticale.
The National Institutes of Health once again designated the Oklahoma Medical Research Foundation an Autoimmunity Center of Excellence, one of only 10 sites in the U.S. The designation was accompanied by a significant federal grant, which OMRF scientists and physicians will use to develop a better understanding of and treatments for autoimmune diseases like lupus, Sjögren's syndrome and multiple sclerosis.
The Dean McGee Eye Institute has completed renovations of its world-class research facilities and recruited additional new clinical and research faculty from throughout the country, including the Wills Eye Hospital, the University of Southern California, Harvard Medical School, and Boston University.
Researchers at the Oklahoma State University Center for Veterinary Health Sciences continue their investigations into targeted disease therapies for both animals and humans. The scientists are developing a number of medical applications of nanotechnology to treat diseases including cancer.
i2E, Inc.invested nearly $2 million in 5 Oklahoma bioscience companies in 2015 and $12 million over the past 16 years.
Oklahomans will have access to the newest cutting-edge therapies, thanks to the Stephenson Cancer Center'sdesignation as a Lead Academic Site by the National Cancer Institute in its new National Clinical Trials Network. Lead Academic Site designation is awarded through a federal research grant that will bring more than $6 million in funding to Oklahoma over the next five years. This designation establishes the Stephenson Cancer Center as a national center of excellence in conducting innovative clinical trials research.
The University of Oklahoma College of Medicine researchers are exploring the effectiveness of a new high-tech treatment for atrial fibrillation, a common heart rhythm disorder. The new approach focuses on stimulating the vagus nerve, a nerve that exists on both sides of the body and plays an important role in helping the heart beat within a safe range. The research is evaluating a stimulator surgically implanted around the vagus nerve.
Additional information is available at www.okbio.org.
• Contributes more than $6.7 billion in economic activity
• Supports more than 51,000 Oklahoma jobs
• Has annual revenues of more than $4.1 billion
• High quality, affordable and available facilities located in Oklahoma City, Stillwater and Ardmore
• Incentives available for qualifying companies
• Dean McGee Eye Institute
• Laureate Institute of Brain Research
• Oklahoma Medical Research Foundation
• Oklahoma State University
• Samuel Roberts Noble Foundation
• University of Oklahoma Health Sciences Center
• Accele BioPharma
• Emergent Technologies
• i2E, Inc.
• Oklahoma Center for the Advancment of Science and Technology
• OKBio Association
• Oklahoma Life Science Fund
• Autoimmune Diseases and Immunology
• Cardiovascular Research
• Glycobiology and Carbohydrates
• Infectious Disease and Microbiology
• Vision Research
• Plant Improvement • Biofuels
• Natural Products for Health
• Value-added Food Products